Kura Oncology Inc.

NASDAQ: KURA · Real-Time Price · USD
7.33
0.73 (11.06%)
At close: Aug 15, 2025, 3:59 PM
7.56
3.21%
After-hours: Aug 15, 2025, 07:56 PM EDT

Kura Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-66.12M -57.43M -19.22M -54.4M -50.84M -49.52M -42.79M -38.6M -37.17M -34.07M -33.11M -35.5M -34.77M -32.45M -32.74M -33.37M -33.66M -30.69M
Depreciation & Amortization
-2.3M 241K 204K -10.05M 202K 234K 214K 216K 213K 206K 206K 193K 183K 177K 166K 160K 124K 108K
Stock-Based Compensation
6.95M 7.84M 8.63M 8.32M 8.43M 8.51M 7.17M 7.09M 6.99M 6.84M 6.8M 6.36M 6.51M 6.65M 6.4M 6.11M 5.99M 5.08M
Other Working Capital
-19.14M 32.06M 269.56M 59K 3.15M -1.79M -3.94M 1.1M 2.23M -1.91M -4.64M 1.23M 2.54M -2.4M 4.12M 1.31M -2.28M -2.4M
Other Non-Cash Items
138K -2.53M -2.75M 10.87M -3.42M -3.15M -7.61M 122K 121K -1.57M -581K 6.72M 794K 1.1M 1.22M 1.19M 1.75M 850K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 5M -2.89M -2.11M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
32.55M -20.05M 282.26M 1.82M 3.1M -4.92M 3.71M 5.04M 6.35M -7.28M 154K 7.58M -3.06M -7.66M 1.6M 1.31M -2.28M -3.86M
Operating Cash Flow
-28.78M -71.93M 269.13M -43.44M -42.53M -48.84M -34.31M -29.03M -25.62M -35.87M -26.53M -21.01M -30.34M -32.18M -23.37M -24.59M -28.07M -28.52M
Capital Expenditures
-1.46M -292K -372K n/a -16K -84K -16K -20K -96K -36K -12K -381K -184K -49K -102K -723K -291K -31K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -26.49K -8.58K 46.23K -11.16K 47.31K n/a -33.28K n/a n/a n/a n/a n/a
Purchase of Investments
-114.6M -268.71M -240.58M -61.73M -161.67M -195.06M -99.69M -96.67M -139.63M -73.83M -106.12M -56.95M -56.18M -51.4M -16.34M -76.23M -129.93M -223.16M
Sales Maturities Of Investments
175M 167.6M 146M 107.26M 204.86M 99.81M 141.9M 105.25M 93.4M 85M 58.82M 129.14M 89.46M 26.49M 90.5M 99.5M 93M 36.97M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 26.49K 8.58K -46.23K 11.16K -47.31K 72.19M 33.28K -24.91M 74.16M 23.27M -36.93M -186.19M
Investing Cash Flow
58.94M -101.41M -94.95M 45.53M 43.17M -95.34M 42.2M 8.56M -46.33M 11.13M -47.32M 71.81M 33.1M -24.96M 74.06M 22.55M -37.22M -186.22M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 10M n/a n/a n/a n/a n/a -6.5M -750K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a 2.56M n/a n/a 431K n/a 24.71M 880K 2.67M 303K 794K 2.26M -66K 829K
Financial Cash Flow
515K 143K 806K 2.2M 3.04M 148.37M 691K 84K 94.01M n/a 34.71M 880K 2.67M 303K 794K 2.26M -6.57M 79K
Net Cash Flow
30.68M -173.19M 174.98M 4.3M 3.68M 4.19M 8.58M -20.38M 22.07M -24.74M -39.13M 51.68M 5.42M -56.84M 51.49M 209K -71.86M -214.66M
Free Cash Flow
-30.23M -72.22M 268.76M -43.44M -42.55M -48.93M -34.32M -29.05M -25.71M -35.91M -26.54M -21.39M -30.52M -32.23M -23.47M -25.32M -28.36M -28.55M